Item request has been placed!
×
Item request cannot be made.
×
Processing Request
[Among adults with cardiovascular disease and BMI≥27kg/m 2 but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?]
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Transliterated Title:
Chez les adultes avec maladie cardiovasculaire et IMC≥27kg/m 2 , mais sans diabète, est-ce que le sémaglutide diminue le risque de mortalité cardiovasculaire, d’infarctus du myocarde ou d’AVC comparativement au placebo tout en étant sécuritaire ?
- Source:
Publisher: Elsevier Country of Publication: France NLM ID: 8101383 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3122 (Electronic) Linking ISSN: 02488663 NLM ISO Abbreviation: Rev Med Interne Subsets: MEDLINE
- Publication Information:
Publication: Paris : Elsevier
Original Publication: Paris : Baillière, [1980-
- Subject Terms:
- Accession Number:
53AXN4NNHX (semaglutide)
0 (Hypoglycemic Agents)
62340-29-8 (Glucagon-Like Peptides)
- Publication Date:
Date Created: 20240116 Date Completed: 20240315 Latest Revision: 20240315
- Publication Date:
20240315
- Accession Number:
10.1016/j.revmed.2024.01.006
- Accession Number:
38228454
No Comments.